Evaluation the Effects of green tea supplement in Covid 19 patients

Not Applicable

Recruiting

• Conditions: covid19.; COVID DISEASE; U07.1

• Registration Number: IRCT20150711023153N3
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

18 years old or above
Written informed consent form
COVID-19 diagnosis based on polymerase chain reaction (PCR)
Willingness to participate in research study

Exclusion Criteria

Pregnancy or lactation
Disseminated intravascular coagulation or any other types of coagulopathy
Severe congestive heart failure by the specialist
Other contraindications prescribed by the specialist
Participation in any clinical trial within the past 30 days prior to enrollment in the present study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CRP. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit.;Erythrocyte Sedimentation Rate (ESR). Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit.;CBC. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Cell counter devices.